Cell lines and commodities: The Hagahai patent case

In March 1995, the United States government issued a patent on a human cell line for an indigenous Hagahai man from the rainforests of Papua New Guinea. The US National Institutes of Health (NIH) were issued patent No. 5,397,696 by the Patent and Trademark Office (PTO), the first time that an indig...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	David Robie
Formato:	article
Lenguaje:	EN
Publicado:	Asia Pacific Network 1997
Materias:	biodiversity health Hagahai indigenous intellectual property rights media ethics Communication. Mass media P87-96 Journalism. The periodical press, etc. PN4699-5650
Acceso en línea:	https://doaj.org/article/775f578950d74ac98983d44d07020bc7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:775f578950d74ac98983d44d07020bc7
record_format	dspace
spelling	oai:doaj.org-article:775f578950d74ac98983d44d07020bc72021-12-02T13:03:24ZCell lines and commodities: The Hagahai patent case10.24135/pjr.v4i1.6221023-94992324-2035https://doaj.org/article/775f578950d74ac98983d44d07020bc71997-11-01T00:00:00Zhttps://ojs.aut.ac.nz/pacific-journalism-review/article/view/622https://doaj.org/toc/1023-9499https://doaj.org/toc/2324-2035 In March 1995, the United States government issued a patent on a human cell line for an indigenous Hagahai man from the rainforests of Papua New Guinea. The US National Institutes of Health (NIH) were issued patent No. 5,397,696 by the Patent and Trademark Office (PTO), the first time that an indigenous person's cells have been patented. Critics saw this is a 'new and dangerous' era in intellectual property rights while even defenders conceded there are serious dilemmas embracing ethics, the law and the media. David RobieAsia Pacific NetworkarticlebiodiversityhealthHagahaiindigenousintellectual property rightsmedia ethicsCommunication. Mass mediaP87-96Journalism. The periodical press, etc.PN4699-5650ENPacific Journalism Review, Vol 4, Iss 1 (1997)
institution	DOAJ
collection	DOAJ
language	EN
topic	biodiversity health Hagahai indigenous intellectual property rights media ethics Communication. Mass media P87-96 Journalism. The periodical press, etc. PN4699-5650
spellingShingle	biodiversity health Hagahai indigenous intellectual property rights media ethics Communication. Mass media P87-96 Journalism. The periodical press, etc. PN4699-5650 David Robie Cell lines and commodities: The Hagahai patent case
description	In March 1995, the United States government issued a patent on a human cell line for an indigenous Hagahai man from the rainforests of Papua New Guinea. The US National Institutes of Health (NIH) were issued patent No. 5,397,696 by the Patent and Trademark Office (PTO), the first time that an indigenous person's cells have been patented. Critics saw this is a 'new and dangerous' era in intellectual property rights while even defenders conceded there are serious dilemmas embracing ethics, the law and the media.
format	article
author	David Robie
author_facet	David Robie
author_sort	David Robie
title	Cell lines and commodities: The Hagahai patent case
title_short	Cell lines and commodities: The Hagahai patent case
title_full	Cell lines and commodities: The Hagahai patent case
title_fullStr	Cell lines and commodities: The Hagahai patent case
title_full_unstemmed	Cell lines and commodities: The Hagahai patent case
title_sort	cell lines and commodities: the hagahai patent case
publisher	Asia Pacific Network
publishDate	1997
url	https://doaj.org/article/775f578950d74ac98983d44d07020bc7
work_keys_str_mv	AT davidrobie celllinesandcommoditiesthehagahaipatentcase
_version_	1718393511427964928

Cell lines and commodities: The Hagahai patent case

Ejemplares similares